SCHEMBL311784

SCHEMBL311784

CCOC(=O)Nc1cc(O)ccc1-c1cc(=O)c2cc(O)c(O)cc2o1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.46
HPGD P15428 9/20 0.45
KDM4E B2RXH2 6/20 0.45
ALDH1A1 P00352 5/20 0.45
HSD17B10 Q99714 4/20 0.45
LMNA P02545 1/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
MAPT P10636 3/20 0.44
POLB P06746 2/20 0.44
GAA P10253 2/20 0.44
BLM P54132 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ALOX12 P18054 2/20 0.44
AKR1B10 O60218 1/20 0.44
USP2 O75604 1/20 0.44
ABL1 P00519 1/20 0.44
PKM P14618 1/20 0.44
MPI P34949 1/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311791 0.91 HPGD (0.51) AKR1B1HPGDKDM4EALDH1A1HSD17B10
SCHEMBL312223 0.91 AKR1B1 (0.56) AKR1B1HPGDKDM4EALDH1A1HSD17B10
SCHEMBL324201 0.87 HPGD (0.61) AKR1B1HPGDKDM4EALDH1A1HSD17B10
SCHEMBL311620 0.86 AKR1B1 (0.43) AKR1B1HPGDKDM4EALDH1A1HSD17B10
SCHEMBL312670 0.86 HPGD (0.42) AKR1B1HPGDKDM4EALDH1A1HSD17B10
SCHEMBL312609 0.84 HPGD (0.42) AKR1B1HPGDKDM4EALDH1A1HSD17B10
SCHEMBL312050 0.84 KDM4E (0.44) HPGDKDM4EALDH1A1HSD17B10LMNA
SCHEMBL312477 0.84 BACE1 (0.61) AKR1B1HPGDKDM4EALDH1A1HSD17B10
SCHEMBL313004 0.84 ATM (0.52) HPGDKDM4EALDH1A1HSD17B10LMNA
SCHEMBL311364 0.84 HPGD (0.44) AKR1B1HPGDKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed